Top Markets
Coin of the day
Medigene AG Medigene AG

Medigene AG

MDG1
Rank in Stocks #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Universitรฉ de Montrรฉal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Share Price
$0.14942078
Last synced: 2025-05-15
Market Cap
$3.86M
Change (1 day)
0.10%
Change (1 year)
0.00%
Country
DE
Trade Medigene AG (MDG1)

Category

Operating Margin for Medigene AG (MDG1)
Operating Margin as of August 2026 TTM: -267.63%
According to Medigene AG latest financial reports and stock price the company's current Operating Margin (TTM) is -267.63%. At the end of 2022 the company had an Operating Margin of -29.19%.
Operating Margin history for Medigene AG from 2004 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -267.63% 0.00%
2023 -267.63% 816.86%
2022 -29.19% -70.94%
2021 -100.46% -70.44%
2020 -339.89% 76.15%
2019 -192.96% -35.54%
2018 -299.35% 34.47%
2017 -222.62% -51.60%
2016 -459.99% 0.84%
2015 -456.18% 1,301.91%
2014 -32.54% -70.38%
2013 -109.84% -39.61%
2012 -181.87% -70.51%
2011 -616.65% -36.38%
2010 -969.29% 1,627.17%
2009 -56.12% -40.06%
2008 -93.62% -38.33%
2007 -151.81% 413.39%
2006 -29.57% -50.33%
2005 -59.53% -51.52%
2004 -122.79% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -100.14%
US
28.81% -100.11%
NL
0.00% -
CH
0.00% -
KR
31.23% -100.12%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.